FDA Adverse Event
Injury
Summary report: N
ENDEAVOR SPRINT RX
MDR report key: 2895933
·
Received January 4, 2013
Report
- Report Number
- 9612164-2013-00017
- Event Type
- Injury
- Date Received
- January 4, 2013
- Date of Event
- October 12, 2012
- Report Date
- January 13, 2014
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BR
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
EVALUATION RESULTS: INHERENT RISK OF PROCEDURE (CVA/STROKE). CONCLUSIONS: INHERENT RISK OF PROCEDURE (CVA/STROKE). (B)(4).
Additional Manufacturer Narrative · 1
(B)(4).
Description of Event or Problem · 1
DURING INDEX PROCEDURE ONE ENDEAVOR SPRINT DRUG ELUTING STENT WAS IMPLANTED IN THE 1ST OBTUSE MARGINAL. APPROXIMATELY 17 DAYS POST INDEX PROCEDURE, DURING A STAGED PROCEDURE, THE PATIENT HAD TWO ENDEAVOR SPRINT DRUG ELUTING STENTS IMPLANTED IN THE LAD. APPROXIMATELY 23 MONTHS POST INDEX PROCEDURE, THE PATIENT SUFFERED A CEREBROVASCULAR ACCIDENT. THE INVESTIGATOR HAS ASSESSED THAT THE EVENT WAS NOT RELATED TO THE DEVICE. IT IS REPORTED THAT THE PATIENT RECOVERED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 5281 | ENDEAVOR SPRINT RX | STENT, CORONARY, DRUG-ELUTING | NIQ | MEDTRONIC IRELAND | 0001139863 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00076 YR | Hospitalization | ASPIRIN |